Computational drug discovery
Molecular discovery at scale
We screened over 6.5 million compounds and identified a SARS-CoV-2 main-protease (3CLpro/Mpro) inhibitor, validated by biochemical assays and crystallography. A separate AI-docking study reported 100× acceleration with no significant change in detection.
First & corresponding author · Mpro study, JCIM 2022
Coauthor · Docking study, Scientific Reports 2023



